Harborview Medical Center to connect with Trestle's MedMicro

TriMed Staff | | Health Imaging | Screening
Digital imaging and telemedicine firm Trestle Holdings Inc. announced that Harborview Medical Center (HMC), a 368-bed patient care, teaching and research facility located in Seattle has purchased MedMicro.

HMC, managed by the University of Washington Medical Center (UWMC), will use MedMicro to connect its neuropathology lab to the Internet, allowing HMC neuropathologists to interactively view and navigate slides in real-time from any remote location with Internet access.

Currently, neurosurgery is performed at HMC and UWMC with the same neuropathologist group serving both locations. With the implementation of MedMicro, the neuropathologists will perform consultations without having to travel between the two facilities.

Trestle Holdings develops and markets digital imaging and telemedicine applications to the life sciences markets. The company's products -- MedReach, MedMicro and MedScan -- link dispersed users with each other, information databases and analytical tools.

TriMed Staff

Related Content

Rising rates of interval breast cancers have experts calling for more risk-based screenings
Rates of breast cancer diagnosis, death expected to climb in coming decades
AI quantifies breast arterial calcifications on mammograms
AI 'not safe' to be implemented as a solo reader for breast cancer screening exams
American College of Radiology announces significant expansion of Lung Cancer Screening Registry
AI beats standard regression models at predicting lung cancer risk

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.